Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name ANRIL
   Synonyms CDKN2B-AS1, ANRIL, CDKN2B-AS, CDKN2BAS, NCRNA00089, PCAT12, p15AS
   Region GRCh38_9:21994778-22121097    Sequence
   Ensembl ENSG00000240498
   RefSeq NR_003529
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name oral cancer
   ICD-0-3 C06.9  
   Methods qPCR,Luciferase reporter assay, in vitro knockdown etc.
   Sample cell lines (HB56, HB96, TSCC, Tca8113, SCC-9 and CAL27,HIOECï¼?HEK-293T),oral cancer tissues
   Expression Pattern up-regulated
   Function Description

ANRIL showed significantly higher, while miR-125a showed lower, expression in OC tissues and sera than in normal controls. MTT, colony formation, flow cytometry analysis, wound-healing, transwell and mice xenograft model assays were used to detect the proliferation, migration, and invasion of ARNIL-overexpressing HB56 cells and ARNIL-knockdown CAL27 cells. The results showed that cell proliferation, migration, and invasion were significantly increased by ARNIL overexpression and decreased by ARNIL silencing in oral cancer cells. Furthermore, we found a negative correlation between ARNIL and miR-125a, and ARNIL acts as a miRNA-sponge by directly interacting with miR-125a.

   Pubmed ID 29635126
   Year 2018
   Title The role of long non-coding RNA ANRIL in the carcinogenesis of oral cancer by targeting miR-125a.
   External Links
   Links for  ANRIL GenBank       HGNC       lncrnadb       Noncode
   Links for  oral cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.